0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation |  ONLINE FIRST
Morton Leibowitz, MD; Tomas Karpati, MD; Chandra J. Cohen-Stavi, MPA; et al.
JAMA Intern Med. Published online June 20, 2016. doi:10.1001/jamainternmed.2016.2751
Includes: Supplemental Content

Review |  ONLINE FIRST
Samia Mora, MD, MHS; JoAnn E. Manson, MD, DrPH
JAMA Intern Med. Published online June 20, 2016. doi:10.1001/jamainternmed.2016.2648

Editorial | 
David L. Brown, MD; Rita F. Redberg, MD, MSc
JAMA Intern Med. 2016;176(5):597-598. doi:10.1001/jamainternmed.2016.0600.

Invited Commentary | 
Walter C. Willett, MD, DrPH
JAMA Intern Med. 2016;176(5):652-653. doi:10.1001/jamainternmed.2016.0494.

Evidence to Practice |  ONLINE FIRST
Samia Mora, MD, MHS
JAMA Intern Med. Published online April 27, 2016. doi:10.1001/jamainternmed.2016.1979

Original Investigation | 
Dima M. Qato, PharmD, MPH, PhD; Jocelyn Wilder, MPH; L. Philip Schumm, MA; et al.
JAMA Intern Med. 2016;176(4):473-482. doi:10.1001/jamainternmed.2015.8581.
Includes: Supplemental Content

Evidence to Practice | 
Daniel A. Ollendorf, PhD; Alexander T. Sandhu, MD; Steven D. Pearson, MD, MSc
JAMA Intern Med. 2016;176(2):249-250. doi:10.1001/jamainternmed.2015.7661.

Invited Commentary | 
David E. Chiriboga, MD, MPH; Ira S. Ockene, MD
JAMA Intern Med. 2016;176(1):95-96. doi:10.1001/jamainternmed.2015.6819.

Original Investigation | 
Ravi V. Shah, MD; Venkatesh L. Murthy, MD, PhD; Laura A. Colangelo, MS; et al.
JAMA Intern Med. 2016;176(1):87-95. doi:10.1001/jamainternmed.2015.6309.
Includes: Supplemental Content

Evidence to Practice | 
Jeffrey A. Tice, MD; Dhruv S. Kazi, MD, MSc, MS; Steven D. Pearson, MD, MSc
JAMA Intern Med. 2016;176(1):107-108. doi:10.1001/jamainternmed.2015.7248.
Includes: CME

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Cardiology
Brief Report  | 
Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure
Gregg C. Fonarow, MD; Adrian F. Hernandez, MD, MHS; Scott D. Solomon, MD; et al.
JAMA
Viewpoint  | 
Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease Shared Decision Making in Clinical Practice
Samia Mora, MD, MHS; Jeffrey M. Ames, BS, MEng; JoAnn E. Manson, MD, DrPH